Stockscreener 앱 받기
1.145
1.33%
0.015
Biodesix Inc 주식(BDSX)의 최신 뉴스
BDSX Stock Rises After Publication of Study Data for Nodify CDT Test - MSN
Biodesix, Inc. (NASDAQ:BDSX) Shares Bought by Barclays PLC - Defense World
Preliminary results show sales boost for Biodesix - BizWest
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) - GlobeNewswire
Biodesix Achieves Record 45% Revenue Growth to $71.3M as Lung Diagnostics Surges in 2024 - StockTitan
Geode Capital Management LLC Has $1.43 Million Stock Position in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study - The Manila Times
Biodesix's Lung Cancer Blood Test Outperforms PET Scans in Major Clinical Study - StockTitan
Biodesix, Inc. (NASDAQ:BDSX) Q3 2024 Earnings Call Transcript - MSN
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Expands By 44.7% - MarketBeat
Contrasting Biodesix (NASDAQ:BDSX) & MDxHealth (NASDAQ:MDXH) - Defense World
Wilmington Savings Fund Society FSB Takes Position in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
Best Project, Interior/Tenant: Biodesix Corporate Headquarters and Laboratory - Engineering News-Record
Insider Buys Additional US$234k In Biodesix Stock - Yahoo Finance
Biodesix director Jack Schuler buys $122,840 in stock By Investing.com - Investing.com Canada
Biodesix director Kennedy Lawrence T. Jr buys $40,561 in stock - Investing.com India
Biodesix director Kennedy Lawrence T. Jr buys $40,561 in stock By Investing.com - Investing.com Canada
Biodesix director Jack Schuler buys $122,840 in stock - Investing.com
Biodesix Inc director Jack Schuler buys $234,000 in shares - Investing.com India
Biodesix Inc director Jack Schuler buys $234,000 in shares By Investing.com - Investing.com UK
With A 26% Price Drop For Biodesix, Inc. (NASDAQ:BDSX) You'll Still Get What You Pay For - Simply Wall St
Biodesix Reports Strong Q3 2024 Growth in Diagnostics - MSN
Biodesix (BDSX) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Biodesix chief commercial officer sells shares worth $644 By Investing.com - Investing.com Australia
Biodesix chief commercial officer sells shares worth $644 - Investing.com India
Biodesix CEO Scott Hutton sells $5,219 in stock - Investing.com India
Biodesix CEO Scott Hutton sells $5,219 in stock By Investing.com - Investing.com Australia
Biodesix CFO Robin Harper Cowie sells $1,355 in stock By Investing.com - Investing.com Australia
Biodesix CFO Robin Harper Cowie sells $1,355 in stock - Investing.com
Biodesix chief accounting officer sells $283 in stock - Investing.com
Insider Buys Additional US$137k In Biodesix Stock - Simply Wall St
Biodesix chairman John Patience acquires $103,710 in stock - Investing.com India
Biodesix chairman John Patience acquires $103,710 in stock By Investing.com - Investing.com Australia
Biodesix director Jack Schuler buys $136k in stock - Investing.com
Biodesix director Kennedy Lawrence T. Jr. acquires $97,068 in stock - Investing.com
Biodesix director Matthew Strobeck acquires $55,915 in stock - Investing.com
Biodesix director Massarany buys $30,865 in common stock - Investing.com India
Biodesix director Kennedy Lawrence T. Jr. acquires $97,068 in stock By Investing.com - Investing.com Nigeria
Earnings call: Biodesix sees strong growth in Q3 with $18.2M revenue - Investing.com India
Brokerages Set Biodesix, Inc. (NASDAQ:BDSX) PT at $3.06 - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of “Buy” from Analysts - Defense World
Biodesix (NASDAQ:BDSX) Releases Quarterly Earnings Results, Meets Expectations - MarketBeat
Biodesix reports Q3 EPS (7c), consensus (7c) - MSN
Biodesix Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
0.97%
자본화:
|
볼륨(24시간):